International Neuroethics Society
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Explanation of Conflict of Interest Disclosure Parts: Part One: All
Explanation of Conflict of Interest Disclosure Parts: Part One: All Financial Involvement with a pharmaceutical or biotechnology company, a company providing clinical assessment, scientific, or medical companies doing business with or proposing to do business with ACNP over past 2 years (Jan. 2011-Present) Part Two: Income Sources & Equity of $10,000 or greater Part Three: Financial Involvement with a pharmaceutical or biotechnology company, a company providing clinical assessment, scientific, or medical products or companies doing business with or proposing to do business with ACNP which constitutes more than 5% of personal income (Jan. 2011-Present): Part Four: Grants from pharmaceutical or biotechnology company, a company providing clinical assessment, scientific, or medical products directly, or indirectly through a foundation, university, or any other organization (Jan. 2011-Present) Part Five: My primary employer is a pharmaceutical/biotech/medical device company. 2012 Program Committee Disclosures Anissa Abi-Dargham: Part 1: Pfizer; Otsuka; Takeda; Sunovion; Shire; Roche; Pierre Favre; Part 2: Pierre Favre William Carlezon: Part 1: Referring to 2010-2011: Scientific Advisory Board, Myneurolab.com; Consultant, Concert Pharmaceuticals; Consultant, Lantheus Medical Imaging; Consultant, Transcept Pharmaceuticals, (Spouse) Senior Scientist, EMD Serono; Part 2: (Spouse) Senior Scientist, EMD Serono, Part 3: (Spouse) Senior Scientist, EMD Serono Cameron Carter: Part1: GlaxoSmithKline research; Part 4: GlaxoSmithKline Karl Deisseroth: Part -
IMH Colloquium Serie
Interdisciplinary Colloquium Series for 2008 - 2009 Sponsored by the UBC INSTITUTE OF MENTAL HEALTH Sept. 10 Barbara Sahakian: Cognition in Depression and Mania WED. Professor of Clinical Neuropsychology, Dept. of Psychiatry and MR/Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge Co-sponsored by National Core for Neuroethics. 2nd talk on TH., Sept. 11, as part of its inaugural ceremonies. Oct. 2 Marten deVries: Minds, Media, & Early Education: Public Mental Health & Media Approaches for Children Under Difficult Conditions & Disaster Professor of Social Psychiatry and Head of Center for Public Mental Health, Maastricht University; Founder, International Inst. Psycho-social and Socio-ecological Research (IPSER) Co-sponsored by Div. of Child & Adolescent Psychiatry. 2nd talk Fri., Oct. 3, noon, at Children’s Hospital: the Dr. Hira Panikkar Memorial Lecture: Babies, Brains & Culture: Health & Development in the Context of Cultural Diversity; Cases from East Africa Nov. 6 Joseph Trimble: Infusing Psychology Courses with Diversity Content: Truths, Half-Truths, and Anecdotes in Cross-Cultural Psychology Professor, Center for Cross-Cultural Research, Dept. of Psychology; Director, Office of Institutional Assessment, Research, and Testing, Western Washington University Co-sponsored by the National Core for Neuroethics. 2nd talk Fri., Nov. 7, noon, Neuroethics Conference Room (Koerner S117): Responsible and Ethical Conduct of Research with Ethnocultural Populations Dec. 11 Steven Marans: Childhood Trauma: Challenges to Listening and Responding Harris Prof. of Child Psychiatry & Prof. of Psychiatry, Child Study Center, Yale University School of Medicine and Director, National Center for Children Exposed to Violence Co-sponsored by Div. of Child & Adolescent Psychiatry. 2nd talk Fri., Dec. 11, noon, at Children’s Hospital: Hands on Problem-Solving in Listening and Responding to Traumatized Children Feb. -
Year in Review 2018
Year in Review 2018 International Neuroethics Society Message from the President I was honored to become President of the International Neuroethics Society in November 2017 and to have a chance to build on the excellent work of my predecessors, Judy Illes, Barbara Sahakian, and Steve Hyman. I set out three goals for my two years as President: • To increase opportunities in the Society for INS members • To boost the public role of the INS in discussions, scholarly and public, of neuroethics and • To increase INS membership. I am pleased to report that we have increased the opportunities for members to take part in the Society’s activities with new committees and task forces. We have reached out to the public through, for example, our public event at the Annual Meeting on ‘My Brain Made Me Buy It? The Neuroethics of Advertising’ and our essay competition in which our members were invited to write for the lay reader. Building our membership, however, has been a little more challenging. Neuroethics is in some ways a niche field but with advances in brain research raising ever more social and ethical dilemmas, it is vital that scientists, philosophers and clinicians become involved. I am eager to get more regional INS meetings, giving opportunities for members to get together apart from the one annual meeting and to spread the word about neuroethics. We have made good progress here in 2018 with events in Oxford, UK; Milwaukee, USA; and Sydney, Australia. We have been developing new partnerships with other like-minded organizations and participating in conferences around the world. -
Functional Neuroimaging Information: a Case for Neuro Exceptionalism
Florida State University Law Review Volume 34 Issue 2 Article 6 2007 Functional Neuroimaging Information: A Case For Neuro Exceptionalism Stacey A. Torvino [email protected] Follow this and additional works at: https://ir.law.fsu.edu/lr Part of the Law Commons Recommended Citation Stacey A. Torvino, Functional Neuroimaging Information: A Case For Neuro Exceptionalism, 34 Fla. St. U. L. Rev. (2007) . https://ir.law.fsu.edu/lr/vol34/iss2/6 This Article is brought to you for free and open access by Scholarship Repository. It has been accepted for inclusion in Florida State University Law Review by an authorized editor of Scholarship Repository. For more information, please contact [email protected]. FLORIDA STATE UNIVERSITY LAW REVIEW FUNCTIONAL NEUROIMAGING INFORMATION: A CASE FOR NEURO EXCEPTIONALISM Stacey A. Torvino VOLUME 34 WINTER 2007 NUMBER 2 Recommended citation: Stacey A. Torvino, Functional Neuroimaging Information: A Case for Neuro Exceptionalism, 34 FLA. ST. U. L. REV. 415 (2007). FUNCTIONAL NEUROIMAGING INFORMATION: A CASE FOR NEURO EXCEPTIONALISM? STACEY A. TOVINO, J.D., PH.D.* I. INTRODUCTION............................................................................................ 415 II. FMRI: A BRIEF HISTORY ............................................................................. 419 III. FMRI APPLICATIONS ................................................................................... 423 A. Clinical Applications............................................................................ 423 B. Understanding Racial Evaluation...................................................... -
Neurolaw Today – a Systematic Review of the Recent Law and Neuroscience Literature
International Journal of Law and Psychiatry 65 (2019) 101341 Contents lists available at ScienceDirect International Journal of Law and Psychiatry Neurolaw today – A systematic review of the recent law and neuroscience literature Jennifer A. Chandler a,⁎,NeilHarrela, Tijana Potkonjak b a Faculty of Law, University of Ottawa, Canada b University of Ottawa, Canada Contents 1. Introduction............................................................... 2 2. Method................................................................. 2 2.1. Objective............................................................. 2 2.2. Searchstrategy.......................................................... 2 2.3. Inclusionandexclusioncriteria................................................... 2 2.4. Analysis............................................................. 3 2.5. Limitations............................................................ 4 3. Results................................................................. 4 3.1. Criminallaw(n=54)....................................................... 4 3.1.1. Adults – criminalresponsibilityandsentencing(n=12)................................... 5 3.1.2. Adults – proceduralandcorrectionalimplications(n=8)................................... 5 3.1.3. Juveniles – criminalresponsibilityandsentencing(n=11).................................. 5 3.1.4. Juveniles – proceduralandcorrectionalimplications(n=23)................................. 5 3.2. Healthlawandpublichealthlaw(n=27)............................................. -
Networks of Expertise and Evidence for Public Policy Annual Report 2015 the Centre for Science and Policy in 2015
Networks of Expertise and Evidence for Public Policy Annual Report 2015 The Centre for Science and Policy in 2015 The policy challenges facing our world today demand ever-greater foresight, ingenuity and a willingness to collaborate across sectors. As this report illustrates, “Over the seven years since its launch, the Centre for Science the Centre for Science and Policy has been helping its network to navigate and Policy has pioneered new ways of bringing academia and challenges from climate resilience to new forms of healthcare; from national government together to tackle policy challenges. CSaP has security to shaping innovation in the public interest. successfully promoted long-term thinking and more robust networks of expertise and evidence for public policy. The maturity of CSaP’s unique network of academics As he moves on to chair CSaP’s Advisory Council, I and policy makers is demonstrated by the breadth would like to express my gratitude to David for his Dr Robert Doubleday and depth of our work during 2015. Our network inspirational work in founding the Centre. Executive Director Centre for Science and Policy 2015 is the year in which the Centre came of age. Having now encompasses over 200 Fellows and more than served as its founding director from 2009 to 2015, I am 1100 researchers and, during the year, we welcomed In 2016, a year set to be every bit as challenging for delighted CSaP is playing a central role in supporting the more than 2500 participants to 43 events. governments as 2015 has been, CSaP’s role in brokering links between research and policy will be University’s mission, and that the Centre is in the excellent These achievements are testimony to the vision of more important than ever. -
'Neuropolitics', 'Neuropolicy' and the Complex Alignment Of
‘Neuropolitics’, ‘neuropolicy’ and the complex alignment of neuroscientific and political theory perspectives Machiel Keestra, Institute for Interdisciplinary Studies, AIS Conference, October 13, 2012 Should we make room for neuro-politics or neuro-policy? Cognitive (neuro-)scientific “insights should make a large “difference for the proper design of political institutions” (Herbert A. Simon, 1985, p. 303) Machiel Keestra - Neuropolitics - AIS conference 13/10/2012 2 Joint & collective action: partial merger with another person’s action plans Analogy between individual coordination & organization and joint action planning (Bratman, 2009) Machiel Keestra - Neuropolitics - AIS conference 13/10/2012 3 How can a cognitive mechanism influence social mechanisms? Machiel Keestra - Neuropolitics - AIS conference 13/10/2012 4 Optimism about neuro-politics Mirror neurons considered a neuronal basis for sympathy, altruism, cooperation, etc. MNS = “capacity to constitute an implicit and directly shared we-centric space” (Gallese, 2006, p. 21). MNS: “the evolutionary process made us wired for empathy” (Marco Iacoboni, 2009, p. 666), Machiel Keestra - Neuropolitics - AIS conference 13/10/2012 5 Pessimism about neuro-politics Psychology & cognitive science demonstrates that humans have 2 processes of cognition: automatic (‘cognitive monster’; Bargh, 1999) controlled Machiel Keestra - Neuropolitics - AIS conference 13/10/2012 6 What fundamental political aspect could be at stake? Group membership is indeed a fundamental issue in political processes, for: “the primary good that we distribute to one another is membership in some human community” (Walzer, 1983, p. 31) Machiel Keestra - Neuropolitics - AIS conference 13/10/2012 7 Group membership as a basis of political strife “Every religious, moral, economic, ethical, or other antithesis transforms into a political one if it is sufficiently strong to group human beings effectively according to friend and enemy” (Schmitt, 1996, p. -
The Neuropolitics of Brain Science and Its Implications for Human Enhancement and Intellectual Property Law
philosophies Article The Neuropolitics of Brain Science and Its Implications for Human Enhancement and Intellectual Property Law Jake Dunagan 1, Jairus Grove 2 and Debora Halbert 2,* 1 Institute for the Future, Palo Alto, CA 94301, USA; [email protected] 2 Department of Political Science, University of Hawaii at Manoa,¯ Honolulu, HI 96822, USA; [email protected] * Correspondence: [email protected] Received: 15 July 2020; Accepted: 23 October 2020; Published: 3 November 2020 Abstract: As we learn more about how the brain functions, the study of the brain changes what we know about human creativity and innovation and our ability to enhance the brain with technology. The possibilities of direct brain-to-brain communication, the use of cognitive enhancing drugs to enhance human intelligence and creativity, and the extended connections between brains and the larger technological world, all suggest areas of linkage between intellectual property (IP) law and policy and the study of the brain science. Questions of importance include: Who owns creativity in such a world when humans are enhanced with technology? And how does one define an original work of authorship or invention if either were created with the aid of an enhancement technology? This paper suggests that new conceptualizations of the brain undermine the notion of the autonomous individual and may serve to locate creativity and originality beyond that of individual creation. In this scenario, the legal fiction of individual ownership of a creative work will be displaced, and as this paper warns, under current conditions the IP policies which may take its place will be of concern absent a rethinking of human agency in the neuropolitical age. -
Panel and Study Groups
Neuropsychopharmacology (2012) 38, S1–S78 & 2012 American College of Neuropsychopharmacology All rights reserved 0893-133X/12 www.neuropsychopharmacology.org S1 Monday, December 03, 2012 Conclusions: The signaling differences identified in this study have important implications in screening different KOR agonists and antago- nists having distinctly different ligand directed signaling properties. Mini Panel Disclosure: C. Chavkin, Part 1: Consulting for Trevena 2010-2011, 1. Renaissance in Opioid Biology: From Preclinical Concepts to Part 2: Contract with Trevena 2010-2011. Clinical Practice 1.2 The Place of Opiates in the Cortico-basal Ganglia Reward 1.1 Molecular Basis for Kappa Opioid Receptor Antagonism: Circuit Implications of Ligand-directed Signaling for the Development of Novel Antidepressants Suzanne Haber* Charles Chavkin* University of Rochester, Rochester, New York University of Washington, Seattle, Washington Background: Reward is a central component for driving incentive- based learning, appropriate responses to stimuli, and habit Background: Preclinical studies have demonstrated the role of formation. Pathology in this circuit is associated with several stress-induced dynorphin release in mediating a component of the diseases including addition. The ventral medial prefrontal cortex anxiogenic and aversive effects of stress exposure. These results (vmPFC), orbital prefrontal cortex (OFC), dorsal anterior cingulate suggest that kappa opioid receptor (KOR) antagonists or low cortex (dACC), striatum, ventral pallidum, and midbrain dopamine efficacy partial agonists may promote stress-resilience in humans neurons are at the center of the circuit associated with reward in and may potentially be useful in treating certain forms of mood general and, in particular addiction. Connectivity between these disorders exacerbated by stressful experience. In rodent models, areas forms a complex neural network that mediates different stress-induced stimulation of dynorphin release produces aversion, aspects of reward processing, that can lead to habit formation. -
The Death and the Resurrection of (Psy) Critique: the Case Of
biblio.ugent.be The UGent Institutional Repository is the electronic archiving and dissemination platform for all UGent research publications. Ghent University has implemented a mandate stipu- lating that all academic publications of UGent researchers should be deposited and ar- chived in this repository. Except for items where current copyright restrictions apply, these papers are available in Open Access. This item is the archived peer-reviewed author-version of: The Death and the Resurrection of (Psy)critique: The Case of Neuroeducation Jan De Vos In: Foundations of Science, Online First, 17 Oct 2014 http://link.springer.com/article/10.1007%2Fs10699-014-9369-8 To refer to or to cite this work, please use the citation to the published version: De Vos, J. (2011). The Death and the Resurrection of (Psy)critique: The Case of Neuroedu- cation. Foundations of Science, Online First, 17 Oct 2014, doi 10.1007/s10699-014-9369-8 1 The Death and the Resurrection of (Psy)critique: The Case of Neuroeducation Abstract A rapidly emerging hegemonic neuro-culture and a booming neural subjectivity signal the entry point for an inquiry into the status of the signifier neuro as a uni- versal passe-partout. The wager of this paper is that the various (mis)appropriations of the neurosciences in the media and in academia itself point to something essential, if not structural, in connection with both the discipline of the neurosciences and the current socio-cultural and ideological climate. Starting from the case of neuroeducation (the application of neuroscience within educa- tion), the genealogy of the neurological turn is linked to the history of psychology and its inextricable bond with processes of psychologisation. -
June 2012 Newsletter
Newsletter “To advance education and research in the science of psychopharmacology for the public benefit” June 2012 2012 SUMMER MEETING, SUNDAY 22 TO WEDNESDAY 25 JULY, HARROGATE INTERNATIONAL CENTRE Full details of sessions are on the website, together with registration facilities http://bap.org.uk/summermeetinghome.php?meetingID=5 Highlights: The 2012 Guest Lecture, presented by Dr Nora Volkow, Director of the National Institute on Drug Abuse (NIDA) Plenary Mental Health Session, “The best treatment for treatment-resistant patients with psychiatric disorders and possibilities for developing clinical research”, including presentations from Stephen Stahl, Guy Goodwin, Gavin Malloch and Kathryn Adcock 9 invited symposia covering cutting-edge clinical and non-clinical psychopharmacology: Drugs as tools in neuropsychiatry: Ketamine; New tricks for old drugs: Opiates, addiction and beyond; Advances in understanding brain corticosteroid responses to stress: relevance to depression; Cognitive impairment in depression: A target for treatment?; New treatment strategies for targeting drug addictions – A translational perspective; Functional imaging markers for monitoring treatment: Mechanisms and efficacy; Schizophrenia Treatment: What’s wrong with it and what might work better; Epigenetics and psychiatry - current understanding and therapeutic potential; Rethinking the compulsive aspects of addiction: From bench to bedside 2 dedicated Poster Sessions Post-doc Symposium, “Neurodevelopmental models of psychiatric disease: back to the future” Satellite -
FEBRUARY 2020 Vol
The Journal of the IYNA INS Edition FEBRUARY 2020 Vol. 3 Issue 2 Featured Articles ‘Ethical Implications ‘Neuromarketing in ‘Nico-teen: The for Electrostimulation Politics: The Ethics of Neuroethics of Ado- and Optogenetics’ a New Age’ lescent Electronic - Dyanne Ahn - Aybala Turkarslan Cigarette Use’ - Jaeah Kim International Youth Neuroscience Association 1 Contents INTRODUCTION Letter from the Editors IYNA Editorial Team page 3 ARTICLES Armstrong? More like Brainstrong: Cognition Kyle Sugita page 4-6 Enhancing Drugs in Academia BCIs – Increasing the Wealth Gap Kalie Uberti page 7-9 Brain-Computer Interfaces: Futuristic Prospects Athena Yao page 10-13 and Ethical Dilemmas Ethical Implications for Electrostimulation and Dyanne Ahn page 14-17 Optogenetics Moving On: A Refugee Crisis Lasya Kambhampati page 18-21 Neuromarketing in Politics: The Ethics of a New Aybala Turkarslan page 22-26 Age Nico-teen: The Neuroethics of Adolescent Jaeah Kim page 27-31 Electronic Cigarette Use Stuck in Modern Limbo: How Can We Help the Milena Malcharek page 32-35 (Un)Conscious Patients? The Problem with Propranolol: Implications of Mustakim Muhurto page 36-38 Memory Dampening Technology Rahman The Rising Conflict Between Neuroscience and Nannarelle page 39-42 Who We Are Hundertmark 2 Treating Unconscious Patients When Sonia Seth page 43-46 End-of-Life Preferences Are Not Declared Who Do We Believe?: The Neuroethics Lauren Kayari page 47-49 Surrounding the #MeToo Movement CONTRIBUTORS PAGE page 50 3 Letter From the Editors Sojas Wagle , Anita Singh, and Anushka Sarda Dear Readers, Welcome to the special INS (International Neuroethics Society) issue of the IYNA Journal! We greatly appreciate your readership, continued or new.